Year archive

Genmab — 2013 filings

All 132 regulatory filings released by Genmab (GMAB) in 2013, sourced directly from the official regulator.

132 Filings

2013 Period

2013 filings (132)

Filing	Released	Lang
Regulatory Filings 2013 Regulatory Filings	2013-12-17	Danish
Regulatory Filings 2013 Regulatory Filings	2013-12-17	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-12-11	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-12-11	English
Remuneration Information 2013 Remuneration Information	2013-12-06	English
Director's Dealing 2013 Director's Dealing	2013-12-06	English
Remuneration Information 2013 Remuneration Information	2013-12-06	Danish
Remuneration Information 2013 Remuneration Information	2013-12-06	English
Earnings Release 2013 Earnings Release FY 2013	2013-12-06	English
Earnings Release 2013 Earnings Release FY 2013	2013-12-06	English
Earnings Release 2013 Earnings Release FY 2013	2013-12-06	Danish
Earnings Release 2013 Earnings Release FY 2013	2013-12-06	English
Environmental & Social Information 2013 Environmental & Social Information	2013-12-04	Danish
Regulatory Filings 2013 Regulatory Filings	2013-12-04	English
Earnings Release 2013 Earnings Release FY 2013	2013-11-26	English
Earnings Release 2013 Earnings Release FY 2013	2013-11-26	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-11-13	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-11-13	English
Regulatory Filings 2013 Regulatory Filings	2013-11-07	Danish
Regulatory Filings 2013 Regulatory Filings	2013-11-07	English
Earnings Release 2013 Earnings Release Q3 2013	2013-10-23	Danish
Earnings Release 2013 Earnings Release Q3 2013	2013-10-23	English
Regulatory Filings 2013 Regulatory Filings	2013-10-18	Danish
Regulatory Filings 2013 Regulatory Filings	2013-10-18	English
GSK and Genmab Announce Submission to US Regulatory Authorities for Arzerra(r) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) Regulatory Filings	2013-10-18	English
Remuneration Information 2013 Remuneration Information	2013-10-10	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-10-10	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-10-10	English
Regulatory Filings 2013 Regulatory Filings	2013-10-10	Danish
Genmab Announces Positive Top-Line Phase II Results of Ofatumumab in Multiple Sclerosis Regulatory Filings	2013-10-10	English
GSK and Genmab Announce European Submission to Regulatory Authorities for Arzerra(r) (Ofatumumab) as 1st Line Treatment of Chronic Lymphocytic Leukemia (CLL) Regulatory Filings	2013-10-04	English
Regulatory Filings 2013 Regulatory Filings	2013-10-04	Danish
Regulatory Filings 2013 Regulatory Filings	2013-10-04	English
Regulatory Filings 2013 Regulatory Filings	2013-09-13	Danish
Regulatory Filings 2013 Regulatory Filings	2013-09-13	English
FDA Grants GSK and Genmab's Arzerra(r) (Ofatumumab) Breakthrough Therapy Designation for Previously Untreated Chronic Lymphocytic Leukemia Legal Proceedings Report	2013-09-13	English
Regulatory Filings 2013 Regulatory Filings	2013-09-10	English
Regulatory Filings 2013 Regulatory Filings	2013-09-10	Danish
Genmab Announces New Study of Daratumumab in Double Refractory Multiple Myeloma Legal Proceedings Report	2013-09-10	English
Regulatory Filings 2013 Regulatory Filings	2013-08-26	English
Regulatory Filings 2013 Regulatory Filings	2013-08-26	Danish
Genmab Reaches Milestone in DuoBody Platform Collaboration with Janssen Regulatory Filings	2013-08-26	English
Director's Dealing 2013 Director's Dealing	2013-08-21	English
Director's Dealing 2013 Director's Dealing	2013-08-21	Danish
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-08-21	Danish
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-08-21	English
Interim / Quarterly Report 2013 Interim / Quarterly Report H1 2013	2013-08-14	Danish
Interim / Quarterly Report 2013 Interim / Quarterly Report H1 2013	2013-08-14	English
Genmab Announces Financial Results for the First Half of 2013 and Improves 2013 Financial Guidance Earnings Release H1 2013	2013-08-14	English
Arzerra(r) Second Quarter 2013 Net Sales Figures Earnings Release Q2 2013	2013-07-24	English
Earnings Release 2013 Earnings Release Q2 2013	2013-07-24	Danish
Earnings Release 2013 Earnings Release Q2 2013	2013-07-24	English
Regulatory Filings 2013 Regulatory Filings	2013-07-18	Danish
Regulatory Filings 2013 Regulatory Filings	2013-07-18	English
Genmab Files IND for HuMax-TF-ADC Regulatory Filings	2013-07-18	English
Genentech and Biogen Idec Refused a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case Regulatory Filings	2013-07-15	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-07-15	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-07-15	English
Regulatory Filings 2013 Regulatory Filings	2013-07-04	Danish
Regulatory Filings 2013 Regulatory Filings	2013-07-04	English
Genmab Collaborator GSK Starts New Ofatumumab Phase III Study in Rare Skin Disorder Legal Proceedings Report	2013-07-04	English
Genmab and ADC Therapeutics Enter Co-Development Collaboration for an Antibody-Drug Conjugate Combining HuMax-TAC and PBD Warhead Regulatory Filings	2013-06-17	English
Remuneration Information 2013 Remuneration Information	2013-06-12	Danish
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-06-12	English
Regulatory Filings 2013 Regulatory Filings	2013-06-11	Danish
Regulatory Filings 2013 Regulatory Filings	2013-06-11	English
Teprotumumab Restarts Clinical Development in New Indication Regulatory Filings	2013-06-11	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-06-11	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-06-11	English
Regulatory Filings 2013 Regulatory Filings	2013-05-31	Danish
Delisting Announcement 2013 Delisting Announcement	2013-05-31	English
Genmab Launches Sponsored Level 1 American Depositary Receipt (ADR) Program Regulatory Filings	2013-05-31	English
Regulatory Filings 2013 Regulatory Filings	2013-05-30	English
Regulatory Filings 2013 Regulatory Filings	2013-05-29	English
Earnings Release 2013 Earnings Release Q2 2013	2013-05-29	English
GSK and Genmab Announce Positive Top-line Results from Pivotal Study of ARZERRA(r) (ofatumumab) Combined with Chlorambucil in Previously Untreated Chronic Lymphocytic Leukemia Earnings Release Q2 2013	2013-05-29	English
Regulatory Filings 2013 Regulatory Filings	2013-05-22	English
Genentech and Biogen Idec Have Filed for a Re-hearing of U.S. Court of Appeals Decision in the Arzerra Patent Infringement Case Legal Proceedings Report	2013-05-17	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-05-17	Danish
Legal Proceedings Report 2013 Legal Proceedings Report	2013-05-17	English
Director's Dealing 2013 Director's Dealing	2013-05-15	English
Director's Dealing 2013 Director's Dealing	2013-05-15	Danish
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-05-15	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-05-15	Danish
Genmab Announces Financial Results for the First Quarter of 2013 Earnings Release Q1 2013	2013-05-07	English
Earnings Release 2013 Earnings Release Q2 2013	2013-05-01	English
Regulatory Filings 2013 Regulatory Filings	2013-05-01	Danish
Genmab Announces Top-Line Phase II Results for Ofatumumab Combined with Bendamustine in Untreated and Relapsed Chronic Lymphocytic Leukemia Regulatory Filings	2013-05-01	English
Daratumumab Receives Breakthrough Therapy Designation from US Food and Drug Administration Regulatory Filings	2013-05-01	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-05-01	English
Regulatory Filings 2013 Regulatory Filings	2013-05-01	Danish
Earnings Release 2013 Earnings Release Q1 2013	2013-04-24	Danish
Earnings Release 2013 Earnings Release Q1 2013	2013-04-24	English
Arzerra First Quarter 2013 Net Sales Figures Earnings Release Q1 2013	2013-04-24	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-04-17	English
Legal Proceedings Report 2013 Legal Proceedings Report	2013-04-17	Danish
Remuneration Information 2013 Remuneration Information	2013-04-17	English
Remuneration Information 2013 Remuneration Information	2013-04-17	Danish
Capital/Financing Update 2013 Capital/Financing Update	2013-04-17	Danish
AGM Information 2013 AGM Information	2013-04-17	English
AGM Information 2013 AGM Information	2013-04-17	Danish
AGM Information 2013 AGM Information	2013-04-17	English
Passing of Genmab A/S' Annual General Meeting AGM Information	2013-04-17	English
Genmab Announces Final US Court Judgment in Favor of Arzerra in Patent Infringement Lawsuit Legal Proceedings Report	2013-04-16	English
Regulatory Filings 2013 Regulatory Filings	2013-04-02	English
Regulatory Filings 2013 Regulatory Filings	2013-04-02	Danish
Daratumumab Granted Fast Track Designation from US Food and Drug Administration Regulatory Filings	2013-04-02	English
Earnings Release 2013 Earnings Release FY 2013	2013-03-25	Danish
Regulatory Filings 2013 Regulatory Filings	2013-03-25	English
Arzerra Receives Approval in Japan Legal Proceedings Report	2013-03-25	English
AGM Information 2013 AGM Information	2013-03-19	English
AGM Information 2013 AGM Information	2013-03-19	Danish
Director's Dealing 2013 Director's Dealing	2013-03-13	English
Director's Dealing 2013 Director's Dealing	2013-03-13	English
Capital/Financing Update 2013 Capital/Financing Update	2013-03-13	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-03-13	Danish
Earnings Release 2012 Earnings Release FY 2012	2013-03-07	English
Annual Report 2012 Annual Report FY 2012	2013-03-07	English
Genmab 2012 Annual Report Report Publication Announcement	2013-03-07	English
Regulatory Filings 2013 Regulatory Filings	2013-03-07	English
Regulatory Filings 2013 Regulatory Filings	2013-03-07	Danish
Legal Proceedings Report 2013 Legal Proceedings Report	2013-02-28	English
Regulatory Filings 2013 Regulatory Filings	2013-02-28	Danish
Genmab Announces Sale of Manufacturing Facility to Baxter Regulatory Filings	2013-02-28	English
Earnings Release 2012 Earnings Release Q4 2012	2013-02-06	English
Earnings Release 2012 Earnings Release Q4 2012	2013-02-06	Danish
Arzerra Fourth Quarter and Full Year 2012 Net Sales Figures Earnings Release Q4 2012	2013-02-06	English
Share Issue/Capital Change 2013 Share Issue/Capital Change	2013-01-31	English
Remuneration Information 2013 Remuneration Information	2013-01-31	English
Major Shareholding Notification 2013 Major Shareholding Notification	2013-01-24	Danish
Major Shareholding Notification 2013 Major Shareholding Notification	2013-01-24	English
Major Shareholder Announcement Major Shareholding Notification	2013-01-24	English

Filings by year

2026 64 filings
2025 190 filings
2024 204 filings
2023 149 filings
2022 190 filings
2021 226 filings
2020 167 filings
2019 213 filings
2018 68 filings
2017 124 filings
2016 229 filings
2015 128 filings
2014 107 filings
2013 132 filings
2012 98 filings
2011 97 filings
2010 133 filings
2009 121 filings
2008 109 filings
2007 70 filings